Serum leptin levels are associated with the presence of syndesmophytes in male patients with ankylosing spondylitis

Clinical Rheumatology

Volumn 31, Issue 8, 2012, Pages 1231-1238

  Kim, Ki Jo ^a   Kim, Ji Young ^a   Park, Su Jung ^a   Yoon, Hosung ^a   Yoon, Chong Hyeon ^a   Kim, Wan Uk ^a   Cho, Chul Soo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Ankylosing spondylitis; Leptin; Syndesmophyte

Indexed keywords

ALKALINE PHOSPHATASE; BONE SPECIFIC ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; LEPTIN; OSTEOCALCIN; TELOPEPTIDE; UNCLASSIFIED DRUG;

ANKYLOSING SPONDYLITIS; ARTICLE; BODY MASS; BONE DENSITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYNDESMOPHYTE;

ADULT; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BODY MASS INDEX; BONE DENSITY; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; HUMANS; LEPTIN; LUMBAR VERTEBRAE; MALE; SPONDYLITIS, ANKYLOSING;

EID: 84866004136     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-012-1999-z     Document Type: Article

References (45)

1. Maksymowych WP (2010) Disease modification in ankylosing spondylitis. Nat Rev Rheumatol 6(2):75-81
2. El Maghraoui A (2004) Osteoporosis and ankylosing spondylitis. Joint Bone Spine 71(4):291-295
3. Donnelly S, Doyle DV, Denton A, Rolfe I, McCloskey EV et al (1994) Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 53(2):117-121
4. Karberg K, Zochling J, Sieper J, Felsenberg D, Braun J (2005) Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J Rheumatol 32(7):1290-1298
5. Rosen CJ, Bouxsein ML (2006) Mechanisms of disease: Is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2(1):35-43
6. Kawai M, Devlin MJ, Rosen CJ (2009) Fat targets for skeletal health. Nat Rev Rheumatol 5(7):365-372
7. Shi Y, Yadav VK, Suda N, Liu XS, Guo XE et al (2008) Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo. Proc Natl Acad Sci USA 105(51):20529-20533
8. Scheller EL, Song J, Dishowitz MI, Soki FN, Hankenson KD et al (2010) Leptin functions peripherally to regulate differentiation of mesenchymal progenitor cells. Stem Cells 28(6):1071-1080
9. Gordeladze JO, Drevon CA, Syversen U, Reseland JE (2002) Leptin stimulates human osteobltic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteocltic signaling. J Cell Biochem 85 (4):825-836
10. Reseland JE, Gordeladze JO (2002) Role of leptin in bone growth: Central player or peripheral supporter? FEBS Lett 528(1-3):40-42
11. Thomas T, Burguera B (2002) Is leptin the link between fat and bone mass? J Bone Miner Res 17(9):1563-1569
12. Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E et al (1997) The metabolic significance of leptin in humans: Gender-bed differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 82(4):1293-1300
13. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361-368
14. Wanders AJ, Landewe RB, Spoorenberg A, Dougados M, van der Linden S et al (2004) What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods bed on the Outcome Meures in Rheumatology Clinical Trials filter. Arthritis Rheum 50(8):2622-2632
15. World Health Organization (1994) sessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of WHO Study Group. World Health Organ Tech Rep Ser 843:1-129
16. Chen K, Li F, Li J, Cai H, Strom S et al (2006) Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat Med 12(4):425-432
17. Park MC, Lee SW, Choi ST, Park YB, Lee SK (2007) Serum leptin levels correlate with interleukin-6 levels and disee activity in patients with ankylosing spondylitis. Scand J Rheumatol 36 (2):101-106
18. Kirchgessner TG, Uysal KT,Wiesbrock SM,MarinoMW, Hotamisligil GS (1997) Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 100(11):2777-2782
19. Zumbach MS, Boehme MW, Wahl P, Stremmel W, Ziegler R et al (1997) Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab 82(12):4080-4082
20. Gilgil E, Kacar C, Tuncer T, Butun B (2005) The association of syndesmophytes with vertebral bone mineral density in patients with ankylosing spondylitis. J Rheumatol 32(2):292-294
21. Toussirot E, Streit G, Nguyen NU, Dumoulin G, Le Huede G et al (2007) Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis. Metabolism 56(10):1383-1389
22. Park MC, Chung SJ, Park YB, Lee SK (2009) Pro-inflammatory effect of leptin on peripheral blood mononuclear cells of patients with ankylosing spondylitis. Joint Bone Spine 76(2):170-175
23. Derdemezis CS, Filippatos TD, Voulgari PV, Tselepis AD, Drosos AA et al (2010) Leptin and adiponectin levels in patients with ankylosing spondylitis. The effect of infliximab treatment. Clin Exp Rheumatol 28(6):880-883
24. Lilja M, Rolandsson O, Shaw JE, Pauvaday V, Cameron AJ et al (2010) Higher leptin levels in Asian Indians than Creoles and Europids: A potential explanation for increased metabolic risk. Int J Obes (Lond) 34(5):878-885
25. van Tubergen A, Ramiro S, van der Heijde D, Dougados M, Mielants H et al (2011) Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: A longitudinal study. Ann Rheum Dis 71:518-23
26. Maksymowych WP, Chiowchanwisawakit P, Clare T, Pedersen SJ, Ostergaard M et al (2009) Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: Evidence of a relationship between inflammation and new bone formation. Arthritis Rheum 60(1):93-102
27. Elefteriou F, Takeda S, Ebihara K, Magre J, Patano N et al (2004) Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci USA 101(9):3258-3263
28. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF et al (2000) Leptin inhibits bone formation through a hypothalamic relay: A central control of bone ms. Cell 100(2):197-207
29. Steppan CM, Crawford DT, Chidsey-Frink KL, Ke H, Swick AG (2000) Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept 92(1-3):73-78
30. Martin A, David V, Malaval L, Lafage-Proust MH, Vico L et al (2007) Opposite effects of leptin on bone metabolism: A dosedependent balance related to energy intake and insulin-like growth factor-I pathway. Endocrinology 148(7):3419-3425
31. Thomas T, Gori F, Khosla S, Jensen MD, Burguera B et al (1999) Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140(4):1630-1638
32. Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG et al (2001) Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 16(8):1426-1433
33. Bajoria R, Sooranna SR, Chatterjee R (2007) Leptin and bone turnover in monochorionic twins complicated by twin-twin transfusion syndrome. Osteoporos Int 18(2):193-200
34. Morberg CM, Tetens I, Black E, Toubro S, Soerensen TI et al (2003) Leptin and bonemineral density: A cross-sectional study in obese and nonobese men. J Clin Endocrinol Metab 88(12):5795-5800
35. Scariano JK, Garry PJ, Montoya GD, Chandani AK, Wilson JM et al (2003) Serum leptin levels, bone mineral density and osteoblast alkaline phosphatase activity in elderly men and women. Mech Ageing Dev 124(3):281-286
36. Ikeda Y, Nakajima A, Aiba A, Koda M, Okawa A et al (2011) Association between serum leptin and bone metabolic markers, and the development of heterotopic ossification of the spinal ligament in female patients with ossification of the posterior longitudinal ligament. Eur Spine J 20(9):1450-1458
37. Kaplan FS, Glaser DL, Hebela N, Shore EM (2004) Heterotopic ossification. J Am Acad Orthop Surg 12(2):116-125
38. Chiowchanwisawakit P, Lambert RG, Conner-Spady B, Maksymowych WP (2011) Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. Arthritis Rheum 63(8):2215-2225
39. Bennett AN, Rehman A, Hensor EM, Marzo-Ortega H, Emery P et al (2010) The fatty Romanus lesion: A non-inflammatory spinal MRI lesion specific for axial spondyloarthropathy. Ann Rheum Dis 69(5):891-894
40. Mutabaruka MS, Aoulad Aissa M, Delalandre A, Lavigne M, Lajeunesse D (2010) Local leptin production in osterthritis subchondral osteoblasts may be responsible for their abnormal phenotypic expression. Arthritis Res Ther 12(1):R20
41. Komaki Y, Sugiura H, Koarai A, Tomaki M, Ogawa H et al (2005) Cytokine-mediated xanthine oxidase upregulation in chronic obstructive pulmonary disease's airways. Pulm armacol Ther 18 (4):297-302
42. Appel H, Maier R, Loddenkemper C, Kayser R, Meier O et al (2010) Immunohistochemical analysis of osteoblasts in zygapophyseal joints of patients with ankylosing spondylitis reveal repair mechanisms similar to osteoarthritis. J Rheumatol 37 (4):823-828
43. Dumond H, Presle N, Terlain B, Mainard D, Loeuille D et al (2003) Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 48(11):3118-3129
44. Donahue RP, Zimmet P, Bean JA, Decourten M, DeCarlo Donahue RA et al (1999) Cigarette smoking, alcohol use, and physical activity in relation to serum leptin levels in a multiethnic population: The Miami Community Health Study. Ann Epidemiol 9 (2):108-113
45. Kelesidis T, Kelesidis I, Chou S, Mantzoros CS (2010) Narrative review: The role of leptin in human physiology: Emerging clinical applications. Ann Intern Med 152(2):93-100